The field of cell and gene therapy is transforming the way patients who are diagnosed with cancers or genetic diseases can be treated. Today, the cost of producing these therapies still represents a major hurdle on the way to the commercialization. New technologies are needed that enable robust and cost-efficient manufacturing and yield replicable high-quality medicines. Although the therapeutic opportunities for patients are exciting, the stakes for patients and drug developers are high.

We want to be your partner, add value to your therapy development process, and drive pioneering therapies to the market. We invest in enabling technologies and build expertise to support the development and commercialization of new innovative therapies. Our scientists and engineers bring decade-long development experience across a broad spectrum of cell types and technologies. That expertise builds the backbone of an extensive service offering, providing you with tailored process and analytical development, manufacturing and regulatory services.

Just fill out this form to view the full PDF and learn more.